THE BACTERICIDAL ACTIVITY OF AMPICILLIN, DAPTOMYCIN, AND VANCOMYCIN AGAINST AMPICILLIN-RESISTANT ENTEROCOCCUS-FAECIUM

被引:9
作者
ELMADY, A
MORTENSEN, JE
机构
[1] ST CHRISTOPHERS HOSP CHILDREN,DEPT LABS,ERIE AVE & FRONT ST,PHILADELPHIA,PA 19134
[2] TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19140
[3] TEMPLE UNIV,COLL ALLIED HLTH,DEPT CLIN LAB SCI,PHILADELPHIA,PA 19122
关键词
D O I
10.1016/0732-8893(91)90049-L
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Ampicillin, daptomycin, and vancomycin, alone and in combination with gentamicin, were examined for bactericidal effects on ampicillin-resistant Enterococcus faecium using broth dilution minimum inhibitory concentrations (MICs) and time-kill studies. We tested 12 ampicillin-resistant isolates and demonstrated the following MICs and MBCs, respectively: ampicillin, greater-than-or-equal-to 32-mu-g/ml and > 256-mu-g/ml; daptomycin, less-than-or-equal-to 4-mu-g/ml and less-than-or-equal-to 16-mu-g/ml; and vancomycin, less-than-or-equal-to 4-mu-g/ml and > 64-mu-g/ml. Time-kill studies demonstrated that daptomycin alone had marked activity against the ampicillin-resistant E. faecium and that the addition of gentamicin resulted in synergistic killing. In addition, ampicillin and vancomycin were not bactericidal for the ampicillin-resistant isolates without the addition of gentamicin. The present study supports the consideration of daptomycin alone or in combination with an aminoglycoside as an alternative therapy for ampicillin-resistant enterococci, although additional clinical experience is now necessary.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 34 条
[1]   HIGH-LEVEL PENICILLIN RESISTANCE AMONG ISOLATES OF ENTEROCOCCI - IMPLICATIONS FOR TREATMENT OF ENTEROCOCCAL INFECTIONS [J].
BUSH, LM ;
CALMON, J ;
CHERNEY, CL ;
WENDELER, M ;
PITSAKIS, P ;
POUPARD, J ;
LEVISON, ME ;
JOHNSON, CC .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (07) :515-520
[2]   DAPTOMYCIN (LY146032) TREATMENT OF EXPERIMENTAL ENTEROCOCCAL ENDOCARDITIS [J].
BUSH, LM ;
BOSCIA, JA ;
KAYE, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) :877-881
[3]  
CHALKLEY LJ, 1985, ANTIMICROB AGENTS CH, V26, P310
[4]   HIGH-LEVEL RESISTANCE TO GENTAMICIN IN CLINICAL ISOLATES OF STREPTOCOCCUS-(ENTEROCOCCUS)-FAECIUM [J].
ELIOPOULOS, GM ;
WENNERSTEN, C ;
ZIGHELBOIMDAUM, S ;
REISZNER, E ;
GOLDMANN, D ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (10) :1528-1532
[5]   INVITRO AND INVIVO ACTIVITY OF LY 146032, A NEW CYCLIC LIPOPEPTIDE ANTIBIOTIC [J].
ELIOPOULOS, GM ;
WILLEY, S ;
REISZNER, E ;
SPITZER, PG ;
CAPUTO, G ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :532-535
[6]   INVITRO ACTIVITY AND MECHANISM OF ACTION OF A21978C1, A NOVEL CYCLIC LIPOPEPTIDE ANTIBIOTIC [J].
ELIOPOULOS, GM ;
THAUVIN, C ;
GERSON, B ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :357-362
[7]   IDENTIFICATION OF ENTEROCOCCUS SPECIES ISOLATED FROM HUMAN INFECTIONS BY A CONVENTIONAL TEST SCHEME [J].
FACKLAM, RR ;
COLLINS, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (04) :731-734
[8]   INVITRO ACTIVITY OF LY146032 AGAINST STAPHYLOCOCCI, STREPTOCOCCI, AND ENTEROCOCCI [J].
FASS, RJ ;
HELSEL, VL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :781-784
[9]   TRANSITION FROM RESISTANCE TO HYPERSUSCEPTIBILITY TO BETA-LACTAM ANTIBIOTICS ASSOCIATED WITH LOSS OF A LOW-AFFINITY PENICILLIN-BINDING PROTEIN IN A STREPTOCOCCUS-FAECIUM MUTANT HIGHLY RESISTANT TO PENICILLIN [J].
FONTANA, R ;
GROSSATO, A ;
ROSSI, L ;
CHENG, YR ;
SATTA, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :678-683
[10]   BINDING OF BETA-LACTAM ANTIBIOTICS TO PENICILLIN-BINDING PROTEINS OF STAPHYLOCOCCUS-AUREUS AND STREPTOCOCCUS-FAECALIS - RELATION TO ANTI-BACTERIAL ACTIVITY [J].
GEORGOPAPADAKOU, NH ;
LIU, FY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (05) :834-836